Focusyl
Focusyl, licence 80038197: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Psynex Pharmaceuticals Inc.
- NPN or DIN-HM
- 80038197
- Status
- Active licence
- Licence date
- 10 December 2012
- Revision date
- Not provided
- Form
- Capsule, remplie de liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1,4-Dihydronicotinamide adenine dinucleotide Source : NADH | 2.5 mg | Not calculated |
| Salix alba Source : Écorce (tige) Potency : 25.0 % Salicin | 50.0 mg | Not calculated |
| [5R-(5alpha,9beta,11E)]-5-Amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5,9-methanocycloocta[b]pyridin-2(1H)-one Source : Huperzine A | 0.05 mg | Not calculated |
| [5R-(5alpha,9beta,11E)]-5-Amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5,9-methanocycloocta[b]pyridin-2(1H)-one Source : Huperzia serrata whole plant, isolate | 0.05 mg | Not calculated |
Non-medicinal ingredients
Lécithine, d-Menthol, Huile de géranium, Saveur de vanille, Huile de graine de Sesamum indicum (Sésame)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to promote endurance and enhance motor performance. Helps to relieve fatigue and helps support mental performance including the ability to concentrate. Helps to promote alertness and wakefulness, and to enhance cognitive performance. Helps to relieve fatigue, to promote endurance, and to enhance motor performance. For support of mental focus and mental stamina.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80038197
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.